RCUS
Arcus Biosciences, Inc.stockNYSE
Market OpenNov 19, 2026 9:46:39 AM EST
15.73USD-0.190%(-0.03)55,217
RCUS Financials
In Q3 FY 2026 (ended ), Arcus Biosciences, Inc. (RCUS) reported revenue of $9M, net income of −$128M, operating cash flow of −$88M, and assets of $818M (filed ).
Loading financial statements…